← All themes

Genomics & Gene Editing

Genomics reads the genetic code and gene editing rewrites it, which can turn an inherited disease from a lifelong condition into a single treatment. Sequencing cost has fallen far enough to make study at population scale routine.

199 stocks

Gene Therapy

#	Name	Funds holding	Growth	Growth %	Fund value
101	101 Global X Genomics & Biotechnology ETF GNOM $95.5M	–	–	–	–
102	102 Genprex GNPX $1.73M	–	–	–	–
103	103 Genenta Science GNTA $32.5M	–	–	–	–
104	104 GRAIL Inc GRAL $5.26B	–	–	–	–
105	GRCL 105 DELISTED Gracell Biotechnologies Inc. American Depositary Shares GRCL	–	–	–	–
106	GRML 106 Greenland Mines Ltd GRML $80.1M	–	–	–	–
107	GTH 107 DELISTED Genetron Holdings Limited ADS GTH	–	–	–	–
108	108 Fractyl Health GUTS $20.6M	–	–	–	–
109	109 Franklin Genomic Advancements ETF HELX $28.8M	–	–	–	–
110	HTGM 110 DELISTED HTG Molecular Diagnostics, Inc. Common Stock HTGM	–	–	–	–
111	111 iShares Genomics Immunology and Healthcare ETF IDNA $306M	–	–	–	–
112	112 Immix Biopharma IMMX $662M	–	–	–	–
113	113 Immatics IMTX $1.02B	–	–	–	–
114	114 IN8bio INAB $10.9M	–	–	–	–
115	115 MiNK Therapeutics INKT $48M	–	–	–	–
116	116 INmune Bio INMB $43.6M	–	–	–	–
117	117 Century Therapeutics IPSC $248M	–	–	–	–
118	KRBP 118 DELISTED Kiromic BioPharma, Inc. Common Stock KRBP	–	–	–	–
119	119 Korro Bio KRRO $125M	–	–	–	–
120	120 Krystal Biotech KRYS $9.37B	–	–	–	–
121	121 Kyverna Therapeutics KYTX $351M	–	–	–	–
122	122 Legend Biotech LEGN $3.59B	–	–	–	–
123	LGVN 123 Longeveron LGVN $4.43M	–	–	–	–
124	124 Lakefront Biotherapeutics American Depositary Shares LKFT $1.96B	–	–	–	–
125	125 Lunai Bioworks LNAI $3.08M	–	–	–	–